This study aimed at determining socio-demographic and clinical factors of primary Sjögren syndrome (pSS) associated with osteoporosis (OP) and fragility fracture. SJOGRENSER is a cross-sectional study of patients with pSS, classified according to American European consensus criteria developed in 33 Spanish rheumatology departments. Epidemiological, clinical, serological and treatment data were collected and a descriptive analysis was conducted. Bivariate and multivariate analyses were performed using a binomial logistic regression to study the factors associated with OP and fragility fracture in pSS. 437 patients were included (95% women, with a median age of 58.6 years). 300 women were menopausal (76.4%). Prevalence of OP was 18.5% [in men (N = 21) this measured 19%]. A total of 37 fragility fractures were recorded. In the multivariate analysis, there was an association between OP and age: in the 51–64 age range (menopausal women), the OR measured 9.993 (95% CI 2301–43,399, p = 0.002); In the age > 64 years group, OR was 20.610 (4.679–90.774, p < 0.001); between OP and disease duration, OR was 1.046 (1.008–1085, p = 0.017); past treatment with corticosteroids, OR 2.548 (1.271–5.105, p = 0.008). Similarly, an association was found between fragility fractures and age: in the 51–64 age group, OR measured 5.068 (1.117–22,995, p = 0.035), age > 64 years, OR was 7.674 (1.675–35,151, p < 0.009); disease duration, OR 1.049 (CI 1.003–1097, p < 0.036) and the ESSDAI index, OR 1.080 (1.029–1134, p = 0.002). Patients with pSS can develop osteoporosis and fragility fractures over the course of the disease. Age, corticosteroids treatment and disease duration were associated with the development of OP. Disease duration and ESSDAI were associated with the development of fractures in patients with pSS.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bowman SJ (2018) Primary Sjögren's syndrome. Lupus 27:32–35
Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F et al (2015) Epidemiology of primary Sjögren síndrome: a systematic review and meta-analysis. Ann Rheum Dis 74:1983–1989
Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, del Pino-Montes J et al (2008) Primary Sjögren síndrome in Spain. Clinical and immunologic expression in 1010 patients. Medicine 87:210–219
Botsios C, Furlan A, Ostuni P, Sfriso P, Andretta M, Ometto F et al (2011) Elderly onset of primary Sjögren's syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Jt Bone Spine 78:171–174
Fernández Castro M, Andreu JL, Sanchez-Piedra C, Martínez Taboada V, Olivé A, Rosas J et al (2016) SJOGREN-SER: registro nacional de pacientes con síndrome de Sjögren primario de la Sociedad Española de Reumatología, objetivos y metodología. Reumatol Clin 12:184–189
Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16:S3–7
Silverman SL, Lane NE (2009) Glucocorticoid-induced osteoporosis. Curr Osteoporos Rep 7:23–26
Kobayashi T, Muto S, Nemoto J et al (2006) Fanconi’s syndrome and distal (type 1) renal tubular acidosis in a patient with primary Sjogren’s syndrome with monoclonal gammopathy of undetermined significance. Clin Nephrol 65:427–432
Weger W, Kotanko P, Weger M, Deutschmann H, Scrabal F (2000) Prevalence and characterization of renal tubular acidosis in patients with osteopenia and osteoporosis and in non-porotic controls. Nephrol Dial Transplant 15:975–980
Baldini C, Delle Sedie A, Luciano N, Pepe P, Ferro F, Talarico R, Tani C, Mosca M (2014) Vitamin D in "early" primary Sjögren's syndrome: does it play a role in influencing disease phenotypes? Rheumatol Int 34:1159–1164
Segal B, Carpenter A, Walk D (2008) Involvement of nervous system pathways in primary Sjö gren’s syndrome. Rheum Dis Clin N Am 34:885–906
Hofbauer LC, Hamann C, Ebeling PR (2010) Approach to the patient with secondary osteoporosis. Eur J Endocrinol 162:1009–1020
Selmi C, Meroni PL, Gershwin ME (2012) Primary biliary cirrhosis and Sjogren's syndrome: autoimmune epithelitis. J Autoimmun 39:34–42
Salman-Monte TC, Torrente-Segarra V, Vega-Vidal AL, Corzo P, Castro-Dominguez F, Ojeda F, Carbonell-Abelló J (2017) Bone mineral density and vitamin D status in systemic lupus erythematosus (SLE): A systematic review. Autoimmun Rev 16:1155–1159
Kim SY, Schneeweiss S, Liu J et al (2010) Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther 12:R154
Hu Z, Zhu S, Liao Z, Zhang B (2016) Impaired bone health in patients with primary Sjogren’s syndrome. In: 2016 ACR/ARHP annual meeting. Abstract number: 2671
Adami G, Fassio A, Rossini M et al (2019) Osteoporosis in rheumatic diseases. Int J Mol Sci 20(23):5867. https://doi.org/10.3390/ijms20235867
Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61:554–558
Pasoto SG, Augusto KL, Alvarenga JC, Takayama L, Oliveira RM, Bonfa E, Pereira RM (2016) Cortical bone density and thickness alterations by high-resolution peripheral quantitative computed tomography: association with vertebral fractures in primary Sjögren's syndrome. Rheumatology (Oxford) 55:2200–2211
Gravani F, Papadaki I, Antypa E, Nezos A, Masselou K, Ioakeimidis D, Koutsilieris M, Moutsopoulos HM, Mavragani CP (2015) Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations. Arthritis Res Ther 17:99
Bhattoa HP, Bettembuk P, Balogh A, Szegedi G, Kiss E (2002) Bone mineral density in women with systemic lupus erythematosus. Clin Rheumatol 21:135–141
Favus MJ (ed) (2006) Enfermedades metabólicas óseas. Epidemiología de la osteoporosis. Autor: Cyrus Coope. Primer on the metabolic bone diseases and disorders of mineral metabolism, 1ª edn (versión en castellano), Barcelona: MedicalTrends, S.L., pp 339–353
Jacobs J, Korswagen LA, Schilder AM et al (2013) Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int 24:1827–1833
Roux C (2011) Osteoporosis in inflammatory joint diseases. Osteoporos Int 22:421–433
Lange U, Teichmann J, Strunk J, Müller-Ladner U, Schmidt KL (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16:1999–2004
Lee C, Almagor O, Dunlop DD et al (2006) Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatology (Oxford) 45:53–60
Buckley LM (2000) Clinical and diagnostic features of glucocorticoid-induced osteoporosis. Clin Exp Rheumatol 18(Suppl 21):S41–43
Ye Z, Lu H, Liu P (2017) Association between essential hypertension and bone mineral density: a systematic review and meta-analysis. Oncotarget 8(40):68916–68927. https://doi.org/10.18632/oncotarget.20325
Gutierrez JO, Zurita MF, Zurita LA (2018) Sjögren's syndrome associated with Fanconi's syndrome and osteomalacia. Am J Case Rep 19:392–396
Jung SW, Park EJ, Kim JS, Lee TW, Ihm CG, Lee SH, Moon JY, Kim YG, Jeong KH (2017) Renal tubular acidosis in patients with primary Sjögren's syndrome. Electrolyte Blood Press 15:17–22
Geng Y, Zhao Y, Zhang Z (2018) Tubulointerstitial nephritis-induced hypophosphatemic osteomalacia in Sjögren's syndrome: a case report and review of the literature. Clin Rheumatol 37:257–263
Shen G, Zhang Y, Hu S, Liu B, Kuang A (2017) Adult-onset hypophosphatemicosteomalacia associated with Sjogren syndrome: clinical case report. Medicine (Baltimore) 96:e6493
Conflict of interest
The authors have declared no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Antonio Naranjo. Hospital de Gran Canaria Doctor Negrín, Iñigo Rúa-Figueroa. Hospital de Gran Canaria Doctor Negrín, Marina Rodríguez López. Hospital de Meixoeiro, Vigo, Coral Mouriño. Hospital de Meixoeiro, Vigo, Óscar Illera. Hospital Infanta Sofía, Madrid, Lurdes Romani. Hospital Virgen de las Nieves, Granada.
About this article
Cite this article
Salman-Monte, T.C., Sanchez-Piedra, C., Fernandez Castro, M. et al. Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome. Rheumatol Int 40, 1259–1265 (2020). https://doi.org/10.1007/s00296-020-04615-3
- Sjögren syndrome
- Osteoporotic fractures
- Bone remodeling